KELSEY ELLIOTT: Open Payments
NPI 1255784781 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,963 in 80 payments from 21 companies in 2025. Trend: 2023 $1,916 · 2024 $1,862 · 2025 $4,963
Consulting: $2,390Food & beverage: $1,596Travel & lodging: $977
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 23 | $3,845 |
| ViiV Healthcare Company | 9 | $185 |
| Smith+Nephew, Inc. | 8 | $166 |
| Amgen Inc. | 7 | $119 |
| ABBVIE INC. | 5 | $97 |
| Organogenesis Inc. | 4 | $87 |
| Indivior Inc. | 4 | $72 |
| Insmed, Inc. | 3 | $62 |
| Aimmune Therapeutics, Inc. | 3 | $53 |
| Astellas Pharma US Inc | 2 | $42 |
Products named: Epclusa, DOVATO, EVENITY, SUBLOCADE, Arikayce, STRAVIX, GRAFIX PL, VOWST.
Industry payments across PA — which companies pay providers there.
